Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("RINI, Brian I")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 97

  • Page / 4
Export

Selection :

  • and

Vascular endothelial growth factor-targeted therapy in renal cell carcinoma : Current status and future directionsRINI, Brian I.Clinical cancer research. 2007, Vol 13, Num 4, pp 1098-1106, issn 1078-0432, 9 p.Article

Molecularly targeted therapy in renal cell carcinoma : where do we go from here?RINI, Brian I.Expert review of anticancer therapy. 2006, Vol 6, Num 12, pp 1753-1760, issn 1473-7140, 8 p.Article

Metastatic Renal Cell Carcinoma: Many Treatment Options, One PatientRINI, Brian I.Journal of clinical oncology. 2009, Vol 27, Num 19, pp 3225-3234, issn 0732-183X, 10 p.Article

Temsirolimus, an Inhibitor of Mammalian Target of RapamycinRINI, Brian I.Clinical cancer research. 2008, Vol 14, Num 5, pp 1286-1290, issn 1078-0432, 5 p.Article

New approaches in advanced renal cell carcinomaRINI, Brian I.Urologic oncology. 2005, Vol 23, Num 1, pp 65-66, issn 1078-1439, 2 p.Article

New Strategies in Kidney Cancer: Therapeutic Advances through Understanding the Molecular Basis of Response and ResistanceRINI, Brian I.Clinical cancer research (Print). 2010, Vol 16, Num 5, pp 1348-1354, issn 1078-0432, 7 p.Article

Clinical effect and future considerations for molecularly-targeted therapy in renal cell carcinoma : Kidney Cancer: Opportunity for Disease Specific Targeted TherapyRINI, Brian I; FLAHERTY, Keith.Urologic oncology. 2008, Vol 26, Num 5, pp 543-549, issn 1078-1439, 7 p.Conference Paper

Castration-Resistant Prostate Cancer: Many Treatments, Many Options, Many Challenges AheadGARCIA, Jorge A; RINI, Brian I.Cancer. 2012, Vol 118, Num 10, pp 2583-2593, issn 0008-543X, 11 p.Article

Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinomaRINI, Brian I; SMALL, Eric J.Journal of clinical oncology. 2005, Vol 23, Num 5, pp 1028-1043, issn 0732-183X, 16 p.Article

Practice and progress in kidney cancer: Methodology for novel drug developmentRINI, Brian I; WEINBERG, Vivian; SMALL, Eric J et al.The Journal of urology. 2004, Vol 171, Num 6, pp 2115-2121, issn 0022-5347, 7 p., 1Article

Renal cell carcinomaRINI, Brian I; CAMPBELL, Steven C; ESCUDIER, Bernard et al.Lancet (British edition). 2009, Vol 373, Num 9669, pp 1119-1132, issn 0140-6736, 14 p.Article

Immunotherapy for metastatic renal cell carcinoma : RCCMCDERMOTT, David F; RINI, Brian I.BJU international (Papier). 2007, Vol 99, Num 5, pp 1282-1288, issn 1464-4096, 7 p., bArticle

The evolving role of surgery for advanced renal cell carcinoma in the era of molecular targeted therapyRINI, Brian I; CAMPBELL, Steven C.The Journal of urology. 2007, Vol 177, Num 6, pp 1978-1984, issn 0022-5347, 7 p.Article

A Phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinomaRINI, Brian I; WEINBERG, Vivian; SMALL, Eric J et al.Cancer. 2005, Vol 103, Num 3, pp 553-558, issn 0008-543X, 6 p.Article

Clinical trials in patients with biochemically relapsed prostate cancerLIN, Amy M; RINI, Brian I; SMALL, Eric J et al.BJU international (Papier). 2006, Vol 97, Num 5, pp 905-910, issn 1464-4096, 6 p.Article

Sorafenib : In advanced renal cancer. CommentaryMCKEAGE, Kate; WAGSTAFF, Antona J; STAEHLER, Michael et al.Drugs (Basel). 2007, Vol 67, Num 3, pp 475-485, issn 0012-6667, 11 p.Article

Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma : biology, clinical results and future developmentRINI, Brian I; SOSMAN, Jeffrey A; MOTZER, Robert J et al.BJU international (Papier). 2005, Vol 96, Num 3, pp 286-290, issn 1464-4096, 5 p.Article

Molecularly targeted therapy in renal cell carcinomaRATHMELL, W. Kimryn; WRIGHT, Tricia M; RINI, Brian I et al.Expert review of anticancer therapy. 2005, Vol 5, Num 6, pp 1031-1040, issn 1473-7140, 10 p.Article

The intersection of sunitinib with the immunosuppressive microenvironment of renal cell carcinoma : implications for future therapeuticsSALAS, Renée N; FINKE, James H; RINI, Brian I et al.Targeted oncology. 2007, Vol 2, Num 4, pp 225-234, issn 1776-2596, 10 p.Article

Prostate-specific antigen kinetics as a measure of the biologic effect of granulocyte-macrophage colony-stimulating factor in patients with serologic progression of prostate cancerRINI, Brian I; WEINBERG, Vivian; BOK, Robert et al.Journal of clinical oncology. 2003, Vol 21, Num 1, pp 99-105, issn 0732-183X, 7 p.Article

The potential for prostate cancer immunotherapyRINI, Brian I; SMALL, Eric J.Critical reviews in oncology/hematology. 2003, Vol 46, pp S117-S125, issn 1040-8428, SUPConference Paper

Flt-3 ligand and sequential FL/interleukin-2 in patients with metastatic renal carcinoma: Clinical and biologic activityRINI, Brian I; PAINTAL, Ajit; VOGELZANG, Nicholas J et al.Journal of immunotherapy (1997). 2002, Vol 25, Num 3, pp 269-277, issn 1524-9557Article

Vascular Endothelial Growth Factor-targeted Therapy in Metastatic Renal Cell CarcinomaRINI, Brian I; ATKINS, Michael; FIGLIN, Robert et al.Cancer. 2009, Vol 115, Num 10, pp 2306-2312, issn 0008-543X, 7 p., SUPConference Paper

Targeted molecular therapy for renal cell carcinomaLANE, Brian R; RINI, Brian I; NOVICK, Andrew C et al.Urology (Ridgewood, NJ). 2007, Vol 69, Num 1, pp 3-10, issn 0090-4295, 8 p.Article

Allogeneic stem-cell transplantation of renal cell cancer after Nonmyeloablative chemotherapy: Feasibility, engraftment, and clinical resultsRINI, Brian I; ZIMMERMAN, Todd; STADLER, Walter M et al.Journal of clinical oncology. 2002, Vol 20, Num 8, pp 2017-2024, issn 0732-183XArticle

  • Page / 4